pamidronate has been researched along with Aging in 3 studies
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with pamidronate improves the clinical course in children with osteogenesis imperfecta (OI), but theoretically might affect longitudinal growth." | 7.72 | Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV. ( Glorieux, FH; Plotkin, H; Rauch, F; Zeitlin, L, 2003) |
| "Treatment with pamidronate improves the clinical course in children with osteogenesis imperfecta (OI), but theoretically might affect longitudinal growth." | 3.72 | Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV. ( Glorieux, FH; Plotkin, H; Rauch, F; Zeitlin, L, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, KW | 1 |
| Zeitlin, L | 1 |
| Rauch, F | 1 |
| Plotkin, H | 1 |
| Glorieux, FH | 1 |
| Bourrin, S | 1 |
| Ammann, P | 1 |
| Bonjour, JP | 1 |
| Rizzoli, R | 1 |
3 other studies available for pamidronate and Aging
| Article | Year |
|---|---|
Transient migratory osteoporosis or insufficiency fracture?
Topics: Aged; Aging; Bone Density Conservation Agents; Diagnosis, Differential; Diphosphonates; Female; Frac | 2009 |
Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV.
Topics: Adolescent; Aging; Body Height; Body Weight; Bone and Bones; Bone Density; Child; Child Development; | 2003 |
Recovery of proximal tibia bone mineral density and strength, but not cancellous bone architecture, after long-term bisphosphonate or selective estrogen receptor modulator therapy in aged rats.
Topics: Aging; Animals; Biomechanical Phenomena; Bone Density; Bone Remodeling; Clomiphene; Diphosphonates; | 2002 |